Tower Research Capital (TRC)’s CB PHARMA ACQUISISTION CORP SHS (CYM) CNLM Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNLM Stock Details CNLM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-303	Closed	-$3K	–	5452
2016 Q1	$3K	Buy	303 +100	+49%	+$1K	﹤0.01%	3268
2015 Q4	$2K	Buy	203 +103	+103%	+$1.02K	﹤0.01%	3944
2015 Q3	$1K	Buy	100 +81	+426%	+$805	﹤0.01%	3824
2015 Q2	$0	Sell	19 -1	-5%	-$10	﹤0.01%	5517
2015 Q1	$0	Buy	+20	New	+$195	﹤0.01%	5359

Tower Research Capital (TRC)'s CNLM Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) in Q2 2016, closing a stake of 303 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in CNLM in Q1 2015 and held it in 5 quarters. The position peaked at $3K in Q1 2016. 0 funds tracked by Wall St. Rank hold CNLM as of Q2 2016.

Tower Research Capital (TRC) reported no remaining CB PHARMA ACQUISISTION CORP SHS (CYM) position as of Q2 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 303 CB PHARMA ACQUISISTION CORP SHS (CYM) shares in Q2 2016, an estimated $3K.
Tower Research Capital (TRC) first reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) in Q1 2015 and held it in 5 quarters.
Tower Research Capital (TRC)'s CB PHARMA ACQUISISTION CORP SHS (CYM) position peaked at $3K in Q1 2016.
0 funds tracked by Wall St. Rank held CB PHARMA ACQUISISTION CORP SHS (CYM) as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.